Liberty Health Sciences (OTCMKTS:LHSIF) Shares Down 2.2% – Should You Sell?

Liberty Health Sciences Inc. (OTCMKTS:LHSIF – Get Free Report)’s stock price dropped 2.2% on Tuesday. The company traded as low as $1.10 and last traded at $1.1446. 671,400 shares were traded during trading, a decline of 60% from the average session volume of 1,668,884 shares. The stock had previously closed at $1.17.

Liberty Health Sciences Price Performance

The stock has a market cap of $392.01 million, a PE ratio of 38.17 and a beta of 1.70. The firm’s 50 day moving average price is $1.14 and its two-hundred day moving average price is $1.14.

About Liberty Health Sciences

(Get Free Report)

Liberty Health Sciences Inc was a Canadian-based cannabis company focused on the cultivation, processing and distribution of medical cannabis products in the United States. Its primary operations were conducted in Florida, where the company served registered medical marijuana patients through a network of retail dispensaries.

The company produced and sold cannabis flower, pre-rolled products, concentrates, oils, capsules and other medical cannabis products under the Liberty Health Sciences brand.

Further Reading

Receive News & Ratings for Liberty Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.